Importantly, genomic data with functional screen have demonstrated that down regulation of mitogen-activated protein kinases (MAPKs) including ERK1/2, by shRNA increased glucocorticoid (prednisolone) sensitivity in ALL cells and primary blasts [2]. The gene discussed is MAPK3; the disease is acute lymphoblastic leukemia.